Question Bank › Self-blame with named internal fix

Self-blame with named internal fix

Calls Tested
988
Answered YES
12
Hit Rate
1.2%
rare by design

TreeHouse Foods, Inc. (THS) — this company's answers

NO on the Q1 2023 call 2023-05-08 B+

← Back to the full THS analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management voluntarily attribute a disappointing result, shortfall, or problem in the just-reported period primarily to a SPECIFIC mistake, misjudgment, or execution failure INSIDE the company (for example: a flawed pricing decision, a botched product launch or transition, a sales-force or go-to-market misstep, an operational or systems error, poor planning or forecasting by the company itself), AND describe a concrete corrective action that is already underway or completed (not merely promised for the future)? Answer YES only if BOTH elements are present in management's own words: (1) plain ownership of an internal, company-caused error as the main driver of the disappointment — not blamed chiefly on macroeconomics, weather, FX, suppliers, customers, competitors, regulation, or 'industry conditions' — and (2) an identified remediation step (such as a leadership or process change, pricing correction, reorganized team, fixed system, or changed playbook) that management says has already been implemented or is actively in progress. Answer NO if there was no acknowledged disappointment or problem; NO if blame is placed mainly on external factors; NO if the acknowledgment is vague ('we can always execute better') without naming what went wrong; NO if the fix is only aspirational or unspecified; and NO if the admission appears only in an analyst's question that management does not itself confirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
JUSHF Jushi Holdings Inc. Q3 2024 2024-11-08 D
BA The Boeing Company Q1 2024 2024-04-24 F
TSSI TSS, Inc. Q4 2022 2023-04-03 D
SCTBF Securitas AB Q2 2018 2018-07-29 D
INSY Insys Therapeutics' Q1 2018 2018-05-08 F
BRSS Global Brass and Copper Holdings' Q4 2017 2018-03-02 C
HOLX Hologic, Inc. Q4 2017 2017-11-08 D
DHXM DHX Media's Q4 2017 2017-09-28 D
ZBH Zimmer Biomet Holdings, Inc. Q2 2017 2017-07-30 F
PTC PTC Inc. Q3 2017 2017-07-19 C+
MODN Model N, Inc. Q3 2016 2016-11-07 F
VRX Valeant Pharmaceuticals International Q1 2016 2016-06-07 F

More from the question bank

Competitor stumble named, demand inboundInsider capital committed alongside shareholNewly won customer expanding beyond initial Capacity sold out ahead of buildCustomers locking in longer commitmentsMilestone beaten early and bar raisedAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.